€57,48 €47,50 excl. VAT
Medium-chain acyl-CoA dehydrogenase (MCAD) is an enzyme that helps the body process medium-chain fatty acids, forming a key part of an animal’s metabolism.
10 working days
From €5,95 shipping and administration per order (incl. VAT)
Specifications
| Breeds | |
|---|---|
| Gene | |
| Organ | |
| specimen | Swab, Blood EDTA, Blood Heparin, Semen, Tissue |
| Mode of Inheritance | |
| Chromosome | |
| Also known as | |
| Year Published |
General information
Medium-chain acyl-CoA dehydrogenase (MCAD) is an enzyme that helps the body process medium-chain fatty acids, forming a key part of an animal’s metabolism. A recessive mutation to the gene ACADM causes an MCAD deficiency. This results in a build-up of medium-chain fatty acids, causing neurological symptoms such as fatigue and seizures. In dogs, MCAD Deficiency is found in the Cavalier King Charles Spaniel.
Clinical features
Dogs affected by MCAD experience a form of epileptic attacks known as complex focal seizures. These episodes are characterized by fatigue/letharghy, decreased awareness and responsiveness, and ataxia (a loss of coordination). They may last anywhere between 20 minutes to multiple hours. The onset of the disease is expected to be between 1 and 2 years of age.
Additional information
References
Pubmed ID: 36292732
Omia ID: 2585